Future Veterinary Diagnostics

被引:4
作者
Dahlhausen, Bob [1 ]
机构
[1] Vet Mol Diagnost Inc, Milford, OH 45150 USA
关键词
biosensor; infectious disease; metabolomics; microarray; polymerase chain reaction; veterinary diagnostics; SINGLE-NUCLEOTIDE POLYMORPHISMS; PROTEIN MICROARRAYS; MOLECULAR BEACONS; INFLUENZA-VIRUSES; DNA MICROARRAYS; GENOME SEQUENCE; MOUTH-DISEASE; GENE; IDENTIFICATION; METABOLOMICS;
D O I
10.1053/j.jepm.2010.05.006
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
The development of rapid, accurate, and sensitive diagnostic methods for detecting pathogens is the basis for treating, controlling, and eradicating infectious diseases of veterinary importance. Scientific and technological advancements have revolutionized the field of veterinary diagnostics. Genome sequencing has allowed efficient, sensitive, and specific diagnostic assays to be developed based on the detection of nucleic acids. The integration of advances in biochemistry, proteomics, engineering, and medicine offers enormous potential for the rapid and accurate diagnosis of viral, microbial, genetic, and metabolic disease. In the future, polymerase chain reaction assays, microarray testing, genomic analysis, and metabolic profiling will be accomplished in a rapid, portable, sensitive, and cost-efficient manner. Copyright 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:117 / 132
页数:16
相关论文
共 95 条
[1]   Comparative analysis of transcript abundance in Pinus sylvestris after challenge with a saprotrophic, pathogenic or mutualistic fungus [J].
Adomas, Aleksandra ;
Heller, Gregory ;
Olson, Ake ;
Osborne, Jason ;
Karlsson, Magnus ;
Nahalkova, Jarmila ;
Van Zyl, Len ;
Sederoff, Ron ;
Stenlid, Jan ;
Finlay, Roger ;
Asiegbu, Frederick O. .
TREE PHYSIOLOGY, 2008, 28 (06) :885-897
[2]   Progress in protein and antibody microarray technology [J].
Angenendt, P .
DRUG DISCOVERY TODAY, 2005, 10 (07) :503-511
[3]   Use of miniaturized protein arrays for Escherichia coli O serotyping [J].
Anjum, Muna F. ;
Tucker, James D. ;
Sprigings, Katherine A. ;
Woodward, Martin J. ;
Ehricht, Ralf .
CLINICAL AND VACCINE IMMUNOLOGY, 2006, 13 (05) :561-567
[4]   Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework [J].
Atkinson, AJ ;
Colburn, WA ;
DeGruttola, VG ;
DeMets, DL ;
Downing, GJ ;
Hoth, DF ;
Oates, JA ;
Peck, CC ;
Schooley, RT ;
Spilker, BA ;
Woodcock, J ;
Zeger, SL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (03) :89-95
[5]   Molecular Diagnostics of Hematologic Malignancies [J].
Avery, Anne .
TOPICS IN COMPANION ANIMAL MEDICINE, 2009, 24 (03) :144-150
[6]  
BERGERON MG, 2001, CLIN CHEM 1998 2001, P217
[7]   Advances in functional protein microarray technology [J].
Bertone, P ;
Snyder, M .
FEBS JOURNAL, 2005, 272 (21) :5400-5411
[8]  
BOSWOOD A, 2009, J VET CARD, V11, pS32
[9]  
Boswood Adrian, 2006, J Vet Cardiol, V8, P1, DOI 10.1016/j.jvc.2005.12.001
[10]   Evolutionarily conserved cytogenetic changes in hematological malignancies of dogs and humans - man and his best friend share more than companionship [J].
Breen, Matthew ;
Modiano, Jaime F. .
CHROMOSOME RESEARCH, 2008, 16 (01) :145-154